Why is Advanced Enzyme falling/rising?

As of 30-Jul, Advanced Enzyme Technologies Ltd is currently priced at 348.50, reflecting a slight increase of 0.1 (0.03%). The stock has shown a positive trend recently, gaining 6.79% over the last three days, although it has underperformed its sector by 1.01% today. In terms of returns, the stock has increased by 4.19% over the past week and 8.47% over the past month, contrasting with the Sensex, which has declined by 1.50% and 2.54% respectively. Despite these short-term gains, the company faces challenges, including a poor long-term growth outlook with a -2.21% annual operating profit growth over the last five years and a significant drop in profits reported for March 2025. Additionally, while the company has a low debt-to-equity ratio and high institutional holdings, the stock's valuation remains high relative to its return on equity of 9.2, indicating potential overvaluation concerns.
In the broader market context, Advanced Enzyme's recent performance stands out against the backdrop of the Sensex, which has seen negative returns in the short term. The stock's year-to-date return of 0.43% is notably lower than the Sensex's 4.28% gain, and its one-year return of -16.63% highlights consistent underperformance against the benchmark. This trend of underperformance has persisted over the last three years, where the stock has generated negative returns compared to the BSE500. Overall, while there are some positive short-term movements and increased investor participation, the long-term growth concerns and recent negative financial results suggest that the stock's upward momentum may be limited.